| Literature DB >> 23898312 |
K K Alichniewicz1, F Brunner, H H Klünemann, M W Greenlee.
Abstract
Performance on tasks that require saccadic inhibition declines with age and altered inhibitory functioning has also been reported in patients with Alzheimer's disease. Although mild cognitive impairment (MCI) is assumed to be a high-risk factor for conversion to AD, little is known about changes in saccadic inhibition and its neural correlates in this condition. Our study determined whether the neural activation associated with saccadic inhibition is altered in persons with amnestic mild cognitive impairment (aMCI). Functional magnetic resonance imaging (fMRI) revealed decreased activation in parietal lobe in healthy elderly persons compared to young persons and decreased activation in frontal eye fields in aMCI patients compared to healthy elderly persons during the execution of anti-saccades. These results illustrate that the decline in inhibitory functions is associated with impaired frontal activation in aMCI. This alteration in function might reflect early manifestations of AD and provide new insights in the neural activation changes that occur in pathological ageing.Entities:
Keywords: Alzheimer's disease (AD); ageing; anti-saccades; fMRI; inhibition functions; mild cognitive impairment
Year: 2013 PMID: 23898312 PMCID: PMC3721022 DOI: 10.3389/fpsyg.2013.00467
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Description of demographic data and results of neuropsychological testing in amnestic mild cognitive impairment (aMCI) and healthy age-matched control groups.
| 19 | 23 | |||
| Age (years) | 58.84 (7.41) | 60.30 (9.31) | 0.55 | 0.582 |
| Gender (M/F) | 8/11 | 5/18 | 2.02 | 0.192 |
| Education (years) | 14.74 (2.26) | 13.09 (3.26) | −1.87 | 0.069 |
| Mini-mental state exam | 29.32 (0.82) | 28.91 (1.13) | −1.30 | 0.201 |
| Verbal fluency | 29.53 (6.15) | 22.61 (5.70) | − | |
| Boston naming test | 14.74 (0.45) | 14.04 (1.11) | − | |
| Word list learning | 22.58 (2.78) | 18.70 (2.99) | − | |
| Word list recall | 8.79 (1.08) | 5.87 (1.71) | − | |
| Word list: savings | 0.97 (0.09) | 0.78 (0.22) | − | |
| Word list intrusions | 0.16 (0.50) | 0.65 (0.98) | ||
| Word list recognition | 20.00 (0.00) | 19.61 (0.66) | − | |
| Phonematic fluency | 18.68 (3.43) | 13.65 (5.01) | − | |
| TMT-A | 30.67 (7.81) | 45.39 (20.41) | ||
| TMT-B | 69.33 (26.42) | 84.83 (35.43) | 1.55 | 0.130 |
| Constructional praxis | 10.95 (0.23) | 10.74 (0.69) | −1.36 | 0.184 |
| Recall of constructional praxis | 10.58 (0.84) | 8.48 (1.93) | − | |
| Constructional praxis: savings | 0.96 (0.06) | 0.79 (0.17) | − | |
Statistical tests of possible group differences (T-values and p-values) are presented.
aMCI, amnestic mild cognitive impairment; denoted are mean values, standard deviations (in brackets), T-, degrees of freedom (df) and p-values.
Clinical characteristics are mean raw-scores from subtests of the neuropsychological test battery contained in the Consortium to Establish a Registry for Alzheimer's Disease Plus (CERAD-Plus).
Significant values (p < 0.05) are marked in bold font.
Performance measured outside of the scanner (proportion correct among executed saccades, proportion of omissions, reaction times in ms) of young persons, healthy elderly and aMCI patients in pro-saccade and anti-saccade task.
| Pro-saccades | 0.99 (0.01) | 0.99 (0.01) | 0.462 (30) | 0.648 | 0.98 (0.03) | 1.100 (40) | 0.278 |
| Omissions | 0.001 (0.0001) | 0.043 (0.208) | −0.956 | 0.339 | 0.071 (0.262) | −0.416 | 0.676 |
| Anti-saccades | 0.96 (0.04) | 0.74 (0.16) | − | 0.57 (0.18) | |||
| Omissions | 0.0045 (0.0006) | 0.023 (0.104) | −0.1.078 | 0.281 | 0.036 (0.089) | −1.496 | 0.135 |
| Pro-saccades | 249.2 (28.3) | 285.6 (53.7) | 306.3 (241.4) | −0.908 (40) | 0.370 | ||
| Antisaccades | 338.5 (21.8) | 478.3 (119.6) | 509.0 (118.6) | −0.804 (40) | 0.427 | ||
aMCI, amnestic mild cognitive impairment; n.s., not significant; denoted are mean values, standard deviations (in brackets), Z- and p-values. Levels of significance indicated by askerisks:
p < 0.05;
p < 0.01.
Note that there were 4 possible target positions. Thus, performance by chance would correspond to a hit rate of 25%.
Significant values (p < 0.05) are marked in bold font.
Anatomical locations of regions of interest in the left and right hemispheres.
| Frontal eye fields | −32 | 16 | 48 |
| 20 | 8 | 48 | |
| Parietal eye fields | 38 | −47 | 48 |
| −43 | −50 | 52 | |
| Supplementary eye fields | 17 | −17 | 56 |
Activation in supplementary eye fields is pooled over left and right hemispheres.
Figure 1Brain areas showing significant activation associated with pro-saccades and anti-saccades in all subject groups (contrasts: pro-saccades > baseline, anti-saccades > baseline). (Panels A,C,E) present the results for the pro-saccade condition, whereas (Panels B,D,F) display the results for the anti-saccade condition. Abbreviations: YHC, young healthy controls; EHC, elderly healthy controls; aMCI, patients with mild cognitive impairment; LH, left hemisphere; RH, right hemisphere; FEF, frontal eye fields; SEF, supplementary eye fields; PEF, parietal eye fields. Color insets present the T-values for the contrast saccade condition vs. baseline.
Results of regions of interest analysis in young persons, healthy elderly and aMCI patients (BOLD response as percent signal change within ROI across all trials).
| Right | 0.20 (0.12) | 0.21 (0.23) | 0.155 (30) | 0.878 | 0.14 (0.13) | 1.238 (40) | 0.223 |
| Left | 0.18 (0.15) | 0.13 (0. 16) | −0.827 (30) | 0.415 | 0.11 (0.10) | 0.308 (40) | 0.759 |
| Right | 0.40 (0.24) | 0.26 (0.20) | −1.670 (30) | 0.106 | 0.23 (0.19) | 0.535 (40) | 0.596 |
| Left | 0. 38 (0.24) | 0. 27 (0. 18) | −1.363 (30) | 0.183 | 0.22 (0.21) | 0.750 (40) | 0.458 |
| 0.17 (0.18) | 0.11 (0.16) | 0.827 (30) | 0.422 | 0.19 (0.27) | −1.237 (40) | 0.223 | |
| Right | 0.32 (0.17) | 0.32 (0. 20) | −0.049 (30) | 0.961 | 0.16 (0.12) | ||
| Left | 0.32 (0.19) | 0. 25 (0.14) | −1.003 (30) | 0.329 | 0.15 (0.15) | ||
| Right | 0.57 (0.21) | 0. 39 (0.20) | − | 0.29 (0.21) | 1.645 (40) | 0.108 | |
| Left | 0.54 (0.17) | 0.37 (0.18) | − | 0.28 (0.22) | 1.532 (40) | 0.133 | |
| 0.20 (0.23) | 0.27 (0.28) | −0.633 (30) | 0.534 | 0.23 (0.34) | 0.406 (40) | 0.687 | |
aMCI, amnestic mild cognitive impairment; denoted are mean values, standard deviations (in brackets), t- and p-values, df: degrees of freedom. Levels of significance indicated by askerisks: *p < 0.05; **p < 0.01.
Significant values (p < 0.05) are marked in bold font.